Asian Pacific journal of cancer prevention : APJCP · 2009
Gastric cancer in Iran 1966-2006.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Mousavi Seyed Mohsen, Somi Mohammad Hossein
Аннотация
This literature review was carried out to provide an up-to-date perspective on gastric cancer clinicoepidemiological characteristics, to explain geographical differences, and to define public health priorities for prevention and early detection programs in Iran. A comprehensive search was conducted using different search engines and over 147 Persian medical journals from 1966 to December 2008. Inclusion criteria were published studies on gastric cancer clinical and epidemiological data. Abstracts only were excluded. Twenty five studies and two national cancer registry reports were also included. The average gastric cancer incidence rates were reported to be 15.2 (8.1 - 49.1) and 6.7(4.9-25.4) per 100,000 in males and females, respectively, with a ratio of 2.3:1 (1.5 - 2.7). More than two thirds of them were diagnosed in stage IV. Crude mortality rates were estimated at 15.5 and 8.4 per 100,000 in males and females. The trend for gastric cancer cases was increase from 1969 to 2004; antral adenocarcinomawas shifted to cardia adenocarcinoma in this period. The gastric cancer epidemiological aspects have changed during 4 decades; a Western pattern has been started in Iran where the incidence rate of adenocarcinoma of the most proximal cardia region and adjacent gastro-oesophageal junction has increased. Developing a gastric cancer early detection program, investigating gastric cancer risk factors, preventing patient and system delays, and providing national guidelines for treatment and palliation are all recommended.